Clinical trial

Rebalancing the Fat Content of the Heart and Muscles

NCT07065383

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Semaglutide administration plus dietary counselling and physical activity encouragement Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Semaglutide plus a personalised and supervised program of resistance and endurance training Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Rebalancing the Fat Content of the Heart and Muscles

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-08-01

PhaseNA

Conditions

Diabetes Mellitus Type 2unresolved

Interventions

Semaglutide administration plus dietary counselling and physical activity encouragementDRUG

Semaglutide plus a personalised and supervised program of resistance and endurance trainingDRUG

Sponsors & collaborators

University of Aberdeenlead sponsor

NHS Grampiancollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07065383 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.